Wuxi Biologics (Cayman) Inc. logo

Wuxi Biologics (Cayman) Inc. (2269)

Market Open
6 Oct, 08:00 AM
HKEX HKEX
57. 90
HKD
+2.5
+4.5126%
HKD
59.1B Market Cap
- P/E Ratio
- Div Yield
19.11M Volume
- Eps
55.4 HKD
Previous Close
Add Transaction
Day Range
56.05 58
Year Range
28.48 58
Want to track 2269 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Wuxi Biologics (Cayman) Inc. (2269) Statistics

Valuation metrics

Market Cap 59.1B
Enterprise value 183.99B
Trailing P/E (ttm) 37.84
Forward P/E -
PEG ratio 1.91
Price/Sales (ttm) 8.03
Price/Book (mrq) 3.9
Enterprise Value/Revenue 7.79
Enterprise Value/EBITDA 19.42

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 22.07M
Average volume (90 days) 32.63M

Price summary

52-Week low 28.48
52-Week high 58
Beta -
50-Day moving average 51.14
200-Day moving average 39.6

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 3:1
Last split Date 16 Nov 2020

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.21%
Operating margin 0.32%

Operational effectiveness

Return on assets 0.08%
Return on equity 0.11%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 5.77
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.22
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 3.18
Total debt (mrq) -
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 3.04%
Book value per share (mrq) 13.32

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -